Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report

doi:10.12998/wjcc.v10.i28.10236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2535)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

124

WORD

HTML

1191

Figures (1-5)

192

Tables (1-1)

269

Sum=1812

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

268

Download

455

Sum=723

Oct 6, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Oct 6, 2022; 10(28): 10236-10243
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10236

Full Size Figure Download Figure

Figure 3 Trend of serum alpha-fetoprotein level during the clinical course.

Citation: Xu SZ, Zhang XC, Jiang Q, Chen M, He MY, Shen P. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report. World J Clin Cases 2022; 10(28): 10236-10243
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10236.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10236